1. Prevalence of moderate coronary disease ranged from 0-52% amongst patients with human immunodeficiency virus (HIV) in this systematic review ...
1. Dolutegravir is associated with greater viral suppression at birth for human immunodeficiency virus (HIV)-positive pregnant patients compared to standard ...
1. Cabotegravir was shown to be superior to TDF-FTC in preventing HIV infection in women. 2. Both drugs were well ...
1. This systematic review identified several facilitators and barriers to health programs conducted in the African American Church, such as ...
1. Single-dose liposomal amphotericin B followed by flucytosine and fluconazole was non-inferior in the treatment of cryptococcal meningitis in HIV-positive ...
1. Treatment with pembrolizumab yielded a best overall response rate of 71%. 2. Adverse events occurred in 76% of patients, ...
1. Compared with generic oral emtricitabine-tenofovir disoproxil fumarate (F/TDF), long-acting injectable cabotegravir (CAB-LA) increased life expectancy by 28,000 QALYs. 2. ...
1. This retrospective cohort study found that patients with immune dysfunction experienced a reduction in COVID-19 infection incidence after full ...
1. Patients initiating care at one substance use disorder clinic had high rates of HCV and several other sexually transmitted ...
1. In the Tigray region of Northern Ethiopia, a relatively low but significant proportion of children with HIV/AIDS on HAART ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.